Lead sponsor

Fundación para la Investigación del Hospital Clínico de Valencia

1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

1

Trials led

1

Active

504

Total enrollment

3

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 4
1

Trials by status

Active, not recruiting
1

Trials led

EPHIC-DIA2BMI 25-40Ph 4Active, not recruiting504